Clinical Microbiology Newsletter RSS feed: Current Issue. Highly respected for its ability to keep pace with advances in this fast moving field, Clinical Microbiology Newsletter has quickly become a “benchmark” for anyone in the lab. Twice a month the newsletter reports on changes that affect your work, ranging from articles on new diagnostic techniques, to surveys of how readers handle blood cultures, to editorials questioning common procedures and suggesting new ones. Clinical Microbiology Newsletter brings you: – minireviews on pathogenesis, diagnosis, epidemiology, therapy of infectious diseases – practical and brief articles on laboratory techniques – indispensable updates on important clinical problems – editorials and opinions on controversial issues in laboratory medicine – helpful tips on improving the laboratory workplace – instructive case reports that describe or resolve difficult or unusual clinical cases. In these days of cost containment and high expectations, Clinical Microbiology Newsletter can help you streamline procedures and improve results.http://www.cmnewsletter.com/?rss=yesElsevier Inc.en © 2010 Elsevier Inc. All rights reserved. Clinical Microbiology Newsletter0196-439932615 March 2010 © 2010 Elsevier Inc. All rights reserved. healthpermissions@elsevier.comhttp://www.cmnewsletter.com/article/PIIS0196439910000103/abstract?rss=yesAbstract: Bloodstream infections and sepsis are among the top causes of mortality in the United States, killing nearly 600 people per day. Many septic patients are treated in emergency medicine departments or critical care units, settings in which rapid administration of targeted antibiotic therapy drastically reduces mortality. Unfortunately, current microbiology laboratory methods are too slow to support rapid interventions, typically requiring >24 hours to detect the presence of bloodstream pathogens (hematopathogens) and at least 3 to 5 days to confirm the selection of appropriate antimicrobial therapy. Moreover, cultures from septic patients are often falsely negative due to pre-emptive therapy, the presence of fastidious organisms, or microbes that are present in low density. As a result, empiric, broad-spectrum treatment is common, a costly approach that may fail to effectively target the correct microbe, may inadvertently harm patients via antimicrobial toxicity, and may contribute to the evolution of drug-resistant microbes. Clearly, new rapid laboratory methods, which enhance laboratory capabilities to diagnose bloodstream infections, will be a useful and welcome addition to clinical microbiology laboratories. Code Sepsis: Rapid Methods To Diagnose Sepsis and Detect Hematopathogens: Part II: Challenges to the Laboratory Diagnosis of SepsisDonna M. Wolk, Albert B. Fiorello10.1016/j.clinmicnews.2010.03.001Clinical Microbiology Newsletter 32, 6 (2010)2010-03-15Clinical Microbiology Newsletter2010-03-15326S0196-4399(10)X0005-84149http://www.cmnewsletter.com/article/PIIS0196439910000115/abstract?rss=yesThe editors of Clinical Microbiology Newsletter extend an invitation to authors who may wish to contribute an article or editorial for publication in CMN. Of special interest are timely topics of interest to clinical microbiologists and infectious disease physicians. Persons with suggestions for articles or editorials should contact the Editor listed to the right to discuss the details of their potential submission.A Special Invitation to Authors10.1016/j.clinmicnews.2010.03.002Clinical Microbiology Newsletter 32, 6 (2010)2010-03-15Clinical Microbiology Newsletter2010-03-15326S0196-4399(10)X0005-85050